HealthA new clinical trial has begun in the Democratic Republic of the Congo as an Ebola outbreak continues to spread. Researchers will investigate Ervebo, a vaccine for the Zaire ebolavirus, against the Bundibugyo strain involved in the current outbreak. The study is intended to assess the vaccine’s performance against that strain. Its launch adds a clinical-testing effort to the response as the outbreak expands.


























